Jacky Devergne serves as the Country Head for Brunei, Indonesia, and Singapore at Baxter International Inc., where he leverages his extensive international experience in healthcare and medical devices to drive strategic growth and operational excellence. With a robust P&L responsibility overseeing a business portfolio exceeding...
Jacky Devergne serves as the Country Head for Brunei, Indonesia, and Singapore at Baxter International Inc., where he leverages his extensive international experience in healthcare and medical devices to drive strategic growth and operational excellence. With a robust P&L responsibility overseeing a business portfolio exceeding USD 40 million, Jacky has demonstrated his ability to navigate both developed and developing markets effectively. Under his leadership, the region achieved an impressive performance to plan of 110%, coupled with a remarkable 17% growth, showcasing his adeptness in implementing market transformation principles that align with aggressive growth strategies.
Jacky's entrepreneurial mindset is evident in his approach to competitive analysis and market positioning, allowing Baxter to capitalize on emerging opportunities within the healthcare landscape. His expertise in international marketing and product development has been instrumental in launching innovative capital equipment and biotechnology solutions tailored to the unique needs of the nephrology sector. Furthermore, he has successfully established a new legal entity for Baxter's local operations, ensuring compliance and operational efficiency while fostering a strong market presence.
As a business leader, Jacky is committed to enhancing healthcare delivery across the region, focusing on sustainable growth and long-term profitability. His proficiency in business intelligence and strategic execution not only drives revenue but also positions Baxter as a trusted partner in improving patient outcomes. With a keen eye on industry trends and a dedication to excellence, Jacky Devergne continues to make significant contributions to the healthcare sector in Brunei, Indonesia, and Singapore.
